1. Academic Validation
  2. Lignans from the Australian Endemic Plant Austrobaileya scandens

Lignans from the Australian Endemic Plant Austrobaileya scandens

  • J Nat Prod. 2016 Jun 24;79(6):1514-23. doi: 10.1021/acs.jnatprod.5b00988.
Trong D Tran 1 Ngoc B Pham 1 Ron Booth 2 Paul I Forster 2 Ronald J Quinn 1
Affiliations

Affiliations

  • 1 Eskitis Institute for Drug Discovery, Griffith University , Brisbane, Queensland 4111, Australia.
  • 2 Queensland Herbarium, DSITI, Brisbane Botanic Gardens , Mt. Coot-tha Road, Brisbane, Queensland 4066, Australia.
Abstract

The sole species of the vascular plant family Austrobaileyaceae, Austrobaileya scandens, is endemic to the tropical rainforest of northeastern Queensland, Australia. A single lead-like enhanced fraction of A. scandens showed potent inhibition against human prostate Cancer PC3 cells. Chemical investigation of this plant resulted in the isolation of two new aryltetralin Lignans, austrobailignans 8 and 9 (1 and 2), and the synthetic compound nicotlactone B (3), newly identified as a natural product together with nine known Lignans (4-12). Their structures were established on the basis of spectroscopic analyses. Absolute configurations of the new compounds were determined by quantum chemical electronic circular dichroism (ECD) calculations employing time-dependent density functional theory. The ECD calculations were also used to assign the absolute configuration of marphenol K (4) and revise the absolute configuration of kadsurindutin C (20). Ten out of the 12 isolated compounds inhibited the growth of PC3 cells with IC50 values ranging from micromolar to nanomolar. Marphenol A (5) was found for the first time to induce Apoptosis and arrest the S cell cycle phase of PC3 cells.

Figures